Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis

Breast Cancer Research and Treatment
Laura EspañaAngels Sierra

Abstract

Lymph node metastasis are the first prognostic factor in breast cancer diagnosis and an early event in metastatic spread. To assess the role of anti-apoptotic proteins in lymph node metastatic progression of human breast cancer cells we analyzed the metastatic activity of MDA-MB-435 cells transfected with the Bcl-xL gene, after orthotopic inoculation in Nude Balb/c and in SCID mice. The luciferase gene was introduced by permanent transfection in the 435/Bcl-xL and 435/Neo cells and used as a tumor marker to measure the number of tumor cells lodged in lymph nodes. We found that 435/Bcl-xL tumor cells had enhanced organ-specific metastatic activity, preferentially lodging in peripheral lymph nodes, where at 45 days post-implantation we found 7 x 10(6) +/- 6 x 10(6) 435/Bcl-xL.luc and 2 +/- 1.1 435/Neo.luc luciferase tagged tumor cell equivalents (TCEs). Metastases were abrogated in mice in which orthotopic tumors were induced with 435/Bcl-xL-antisense cells. Additionally, in vitro experiments show that in 435 cells Bcl-xL-antisense can override the emergence of resistance to apoptosis induced by TNF- alpha and TGF- beta in cells overexpressing Bcl-xL, increasing also adhesion to extracellular matrix proteins. These results point ...Continue Reading

References

Mar 1, 1992·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D Rusciano, M M Burger
Jan 1, 1994·Journal of Cell Science. Supplement·D M Hockenbery
Jan 1, 1997·Annual Review of Medicine·C M Rudin, C B Thompson
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·U RodeckD L Ewert
May 1, 1997·Breast Cancer Research and Treatment·S J Nass, R B Dickson
Aug 1, 1997·Breast Cancer Research and Treatment·M Reiss, M H Barcellos-Hoff
Oct 23, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D Del BufaloG Zupi
May 16, 1998·International Journal of Cancer. Journal International Du Cancer·A SierraA Fabra
Jan 16, 1999·Journal of the National Cancer Institute·T G KarrisonP Meier
May 26, 1999·The Journal of Pathology·I R Hart
Nov 5, 1999·Advances in Cancer Research·A Wells
Apr 25, 2000·Cell Death and Differentiation·Y FernándezA Sierra
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·A P Simões-WüstU Zangemeister-Wittke
May 15, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·N RubioA Sierra
May 18, 2001·Nature·L A Liotta, E C Kohn
Jul 28, 2001·Trends in Immunology·M J Smyth, J A Trapani
Mar 5, 2002·The Journal of Investigative Dermatology·Robert A OlieUwe Zangemeister-Wittke
Oct 17, 2002·The Journal of Biological Chemistry·Danielle R MercatanteRyszard Kole

❮ Previous
Next ❯

Citations

Jun 14, 2006·Cancer Metastasis Reviews·Stanley P L LeongM Kitajima
Oct 7, 2008·Oncogene·T J Stewart, S I Abrams
Jun 13, 2009·The Journal of Biological Chemistry·Timothée RevilBenoit Chabot
Jun 19, 2008·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Martin Hofmann-ApitiusChristoph M Friedrich
Feb 9, 2013·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Dong-Hui ZhouAnna Trauzold
Jan 22, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·S Kalla SinghD De León
Jul 11, 2008·Immunological Reviews·Anne O'GarraCatherine Hawrylowicz
Sep 3, 2013·Journal of Molecular Recognition : JMR·Vikas BhatAmjad Farooq
Jun 28, 2005·Surgical Oncology Clinics of North America·Subramanian NatarajanBlake Cady
Mar 24, 2012·Biochemical and Biophysical Research Communications·Jaehoon LeeHaihong Shen
Mar 21, 2018·The Journal of Clinical Investigation·Li BaoHenrik J Ditzel
Jan 21, 2016·Nature Communications·Soyoung ChoiYi-Chieh Nancy Du
Dec 12, 2013·Expert Review of Clinical Immunology·Alka Bhatia, Yashwant Kumar
Apr 17, 2020·Expert Opinion on Biological Therapy·Adrian PelinRagunath Singaravelu
May 22, 2008·World Journal of Gastroenterology : WJG·You-Li ZhangYu Fan
Sep 26, 2019·Frontiers in Genetics·Megan Stevens, Sebastian Oltean
Feb 23, 2019·Cell Death & Disease·Chloe F A WarrenNikola A Bowden
Jun 21, 2020·Signal Transduction and Targeted Therapy·Lei LiuShouping Xu
Apr 13, 2017·BMC Complementary and Alternative Medicine·Sarfraz Ahmed, Nor Hayati Othman
Mar 7, 2021·International Journal of Molecular Sciences·Zbigniew WyżewskiKarolina Paulina Gregorczyk-Zboroch
Jul 3, 2021·Cancers·Luiza HandschuhKrzysztof Lewandowski
Jul 27, 2021·MedComm·Tiantian ZhangYi-Chieh Nancy Du

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis